Bio-Rad Accelerates Production of Its Platelia SARS-CoV-2 Total Ab Test with Demonstrated Diagnostic Specificity of More Than 99 Percent and Diagnostic Sensitivity of 100 Percent

  HERCULES, Calif.–June 30, 2020 –Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and…